Overview of clinical trials with new agents

Transplant Proc. 2001 May;33(3):2201-3. doi: 10.1016/s0041-1345(01)01941-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Basiliximab
  • Clinical Trials as Topic
  • Daclizumab
  • Drug Therapy, Combination
  • Graft Survival
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology
  • Multicenter Studies as Topic
  • Recombinant Fusion Proteins*
  • Sirolimus / therapeutic use
  • Survival Rate
  • Transplantation Immunology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Basiliximab
  • Daclizumab
  • Sirolimus